Monika Jansson

About me
Publications
CV
Public outreach and news

About me

Monika Jansson is a Med Lic biomedical scientist, specialized in
hematological cytogenetics (chromosome karyotyping and FISH). She works as
senior biomedical scientist in the MDS Research Group [1] at HERM.
[1] http://ki.se/en/medh/eva-hellstrom-lindberg-group

Research

She is in charge of the sample handling/preparation of the MDS biobank and
coordinates the Scarab LIMS system within the MDS biobank. She is also Lab
Manager for HERM.
Thesis [1]
[1] http://publications.ki.se/xmlui/handle/10616/40233

Articles

Article: BLOOD ADVANCES. 2021;5(4):1003-1016

Challenging conventional karyotyping by next-generation karyotyping in 281 intensively treated patients with AML.

Mareschal S; Palau A; Lindberg J; Ruminy P; Nilsson C; Bengtzén S; Engvall M; Eriksson A; Neddermeyer A; Marchand V; Jansson M; Björklund M; Jardin F; Rantalainen M; Lennartsson A; Cavelier L; Grönberg H; Lehmann S
Article: LEUKEMIA. 2020;34(1):271-282

A three-dimensional in vitro model of erythropoiesis recapitulates erythroid failure in myelodysplastic syndromes.

Elvarsdóttir EM; Mortera-Blanco T; Dimitriou M; Bouderlique T; Jansson M; Hofman IJF; Conte S; Karimi M; Sander B; Douagi I; Woll PS; Hellström-Lindberg E
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2018;180(4):526-533

Megakaryocytes harbour the del(5q) abnormality despite complete clinical and cytogenetic remission induced by lenalidomide treatment.

Scharenberg C; Jansson M; Saft L; Hellström-Lindberg E
Article: BLOOD. 2017;130(7):881-890

SF3B1-initiating mutations in MDS-RSs target lymphomyeloid hematopoietic stem cells.

Mortera-Blanco T; Dimitriou M; Woll PS; Karimi M; Elvarsdottir E; Conte S; Tobiasson M; Jansson M; Douagi I; Moarii M; Saft L; Papaemmanuil E; Jacobsen SEW; Hellström-Lindberg E
Article: ONCOTARGET. 2017;8(17):28812-28825

Comprehensive mapping of the effects of azacitidine on DNA methylation, repressive/permissive histone marks and gene expression in primary cells from patients with MDS and MDS-related disease.

Tobiasson M; Abdulkadir H; Lennartsson A; Katayama S; Marabita F; De Paepe A; Karimi M; Krjutskov K; Einarsdottir E; Grövdal M; Jansson M; Ben Azenkoud A; Corddedu L; Lehmann S; Ekwall K; Kere J; Hellström-Lindberg E; Ungerstedt J
Article: ONCOTARGET. 2016;7(16):22103-22115

Mutations in histone modulators are associated with prolonged survival during azacitidine therapy.

Tobiasson M; McLornan DP; Karimi M; Dimitriou M; Jansson M; Ben Azenkoud A; Jädersten M; Lindberg G; Abdulkadir H; Kulasekararaj A; Ungerstedt J; Lennartsson A; Ekwall K; Mufti GJ; Hellström-Lindberg E
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2015;171(4):478-490

Aberrant splicing of genes involved in haemoglobin synthesis and impaired terminal erythroid maturation in SF3B1 mutated refractory anaemia with ring sideroblasts.

Conte S; Katayama S; Vesterlund L; Karimi M; Dimitriou M; Jansson M; Mortera-Blanco T; Unneberg P; Papaemmanuil E; Sander B; Skoog T; Campbell P; Walfridsson J; Kere J; Hellström-Lindberg E
Article: BLOOD. 2015;126(2):233-241

SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts.

Malcovati L; Karimi M; Papaemmanuil E; Ambaglio I; Jädersten M; Jansson M; Elena C; Gallì A; Walldin G; Della Porta MG; Raaschou-Jensen K; Travaglino E; Kallenbach K; Pietra D; Ljungström V; Conte S; Boveri E; Invernizzi R; Rosenquist R; Campbell PJ; Cazzola M; Hellström Lindberg E
Article: METHODS IN MOLECULAR BIOLOGY. 2015;1313:131-139

FISH Detection of X and Y Chromosomes in Combination with Immunofluorescence to Study Contribution of Transplanted Cells to Skeletal Muscle Fibers.

Strömberg A; Jansson M
Article: BLOOD CANCER JOURNAL. 2014;4(3):e189

Limited clinical efficacy of azacitidine in transfusion-dependent, growth factor-resistant, low- and Int-1-risk MDS: Results from the nordic NMDSG08A phase II trial.

Tobiasson M; Dybedahl I; Holm MS; Karimi M; Brandefors L; Garelius H; Grövdal M; Högh-Dufva I; Grønbæk K; Jansson M; Marcher C; Nilsson L; Kittang AO; Porwit A; Saft L; Möllgård L; Hellström-Lindberg E
Article: SKELETAL MUSCLE. 2013;3(1):12

Bone marrow derived cells in adult skeletal muscle tissue in humans.

Strömberg A; Jansson M; Fischer H; Rullman E; Hägglund H; Gustafsson T
Article: LEUKEMIA. 2013;27(4):889-896

The transporter ABCB7 is a mediator of the phenotype of acquired refractory anemia with ring sideroblasts.

Nikpour M; Scharenberg C; Liu A; Conte S; Karimi M; Mortera-Blanco T; Giai V; Fernandez-Mercado M; Papaemmanuil E; Högstrand K; Jansson M; Vedin I; Wainscoat JS; Campbell P; Cazzola M; Boultwood J; Grandien A; Hellström-Lindberg E
Article: HAEMATOLOGICA. 2011;96(7):963-971

Clinical effect of increasing doses of lenalidomide in high-risk myelodysplastic syndrome and acute myeloid leukemia with chromosome 5 abnormalities.

Möllgård L; Saft L; Treppendahl MB; Dybedal I; Nørgaard JM; Astermark J; Ejerblad E; Garelius H; Dufva IH; Jansson M; Jädersten M; Kjeldsen L; Linder O; Nilsson L; Vestergaard H; Porwit A; Grønbæk K; Hellström-Lindberg E
Article: LEUKEMIA RESEARCH. 2010;34(12):1627-1629

Constitutional inv(3) in myelodysplastic syndromes.

Gahrton C; Nahi H; Jansson M; Wallblom A; Alici E; Sutlu T; Samuelsson J; Gahrton G
Article: LEUKEMIA. 2010;24(5):932-941

Gene-specific and global methylation patterns predict outcome in patients with acute myeloid leukemia.

Deneberg S; Grövdal M; Karimi M; Jansson M; Nahi H; Corbacioglu A; Gaidzik V; Döhner K; Paul C; Ekström TJ; Hellström-Lindberg E; Lehmann S
Article: ONCOLOGY REPORTS. 2009;22(1):137-142

Impact of chromosome 13 deletion and plasma cell load on long-term survival of patients with multiple myeloma undergoing autologous transplantation.

Paul E; Sutlu T; Deneberg S; Alici E; Björkstrand B; Jansson M; Lerner R; Wallblom A; Gahrton G; Nahi H
Article: BONE MARROW TRANSPLANTATION. 2008;41(10):895-904

The effect of administration order of BU and CY on engraftment and toxicity in HSCT mouse model.

Sadeghi B; Jansson M; Hassan Z; Mints M; Hägglund H; Abedi-Valugerdi M; Hassan M
Article: LEUKEMIA & LYMPHOMA. 2008;49(3):508-516

Chromosomal aberrations in 17p predict in vitro drug resistance and short overall survival in acute myeloid leukemia.

Nahi H; Lehmann S; Bengtzen S; Jansson M; Möllgård L; Paul C; Merup M
Article: HUMAN REPRODUCTION. 2008;23(1):139-143

Endometrial endothelial cells are derived from donor stem cells in a bone marrow transplant recipient.

Mints M; Jansson M; Sadeghi B; Westgren M; Uzunel M; Hassan M; Palmblad J
Article: TRANSPLANTATION. 2005;79(11):1607-1614

Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta.

Le Blanc K; Götherström C; Ringdén O; Hassan M; McMahon R; Horwitz E; Anneren G; Axelsson O; Nunn J; Ewald U; Nordén-Lindeberg S; Jansson M; Dalton A; Aström E; Westgren M
Article: EXPERIMENTAL HEMATOLOGY. 2005;33(3):380-387

Effect of altering administration order of busulphan and cyclophosphamide on the myeloablative and immunosuppressive properties of the conditioning regimen in mice.

Nilsson C; Forsman J; Hassan Z; Abedi-Valugerdi M; O'Connor C; Concha H; Jansson M; Hassan M
Article: TRANSPLANTATION. 2004;78(1):154-157

Lung epithelial cells and type II pneumocytes of donor origin after allogeneic hematopoietic stem cell transplantation.

Mattsson J; Jansson M; Wernerson A; Hassan M
Article: GENOMICS. 2000;70(3):327-334

Comparative sequence analysis of a region on human chromosome 13q14, frequently deleted in B-cell chronic lymphocytic leukemia, and its homologous region on mouse chromosome 14.

Kapanadze B; Makeeva N; Corcoran M; Jareborg N; Hammarsund M; Baranova A; Zabarovsky E; Vorontsova O; Merup M; Gahrton G; Jansson M; Yankovsky N; Einhorn S; Oscier D; Grandér D; Sangfelt O
Article: GENOMICS. 1999;60(2):161-171

Molecular analysis of the human chromosome 5q13.3 region in patients with hairy cell leukemia and identification of tumor suppressor gene candidates.

Wu X; Ivanova G; Merup M; Jansson M; Stellan B; Grandér D; Zabarovsky E; Gahrton G; Einhorn S
Article: GENOMICS. 1999;56(2):184-196

Structure and chromosomal assignment of the sterol 12alpha-hydroxylase gene (CYP8B1) in human and mouse: eukaryotic cytochrome P-450 gene devoid of introns.

Gåfvels M; Olin M; Chowdhary BP; Raudsepp T; Andersson U; Persson B; Jansson M; Björkhem I; Eggertsen G
Article: LEUKEMIA. 1998;12(5):705-709

A FISH cosmid 'cocktail' for detection of 13q deletions in chronic lymphocytic leukaemia--comparison with cytogenetics and Southern hybridization.

Merup M; Jansson M; Corcoran M; Liu Y; Wu X; Rasool O; Stellan B; Hermansson M; Juliusson G; Gahrton G; Einhorn S
Article: GENES CHROMOSOMES & CANCER. 1997;20(4):337-346

Characterization of a hairy cell leukemia-associated 5q13.3 inversion breakpoint.

Wu X; Merup M; Juliusson G; Jansson M; Stellan B; Grandér D; Zabarovsky E; Liu Y; Spasokoukotskaja T; Gahrton G; Einhorn S
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 1997;58(3):174-180

Amplification of multiple regions of chromosome 12, including 12q13-15, in chronic lymphocytic leukaemia.

Merup M; Juliusson G; Wu X; Jansson M; Stellan B; Rasool O; Röijer E; Stenman G; Gahrton G; Einhorn S
Show more

All other publications

Letter: BLOOD CANCER JOURNAL. 2017;7(10):e616

Bone marrow stroma cells derived from mononuclear cells at diagnosis as a source of germline control DNA for determination of somatic mutations in acute myeloid leukemia.

Mujahed H; Jansson M; Bengtzén S; Lehamnn S
Letter: HAEMATOLOGICA. 2015;100(6):e223-e225

High-throughput mutational screening adds clinically important information in myelodysplastic syndromes and secondary or therapy-related acute myeloid leukemia.

Karimi M; Nilsson C; Dimitriou M; Jansson M; Matsson H; Unneberg P; Lehmann S; Kere J; Hellström-Lindberg E
Letter: LEUKEMIA. 2014;28(2):411-413

Azacitidine induces profound genome-wide hypomethylation in primary myelodysplastic bone marrow cultures but may also reduce histone acetylation.

Grövdal M; Karimi M; Tobiasson M; Reinius L; Jansson M; Ekwall K; Ungerstedt J; Kere J; Greco D; Hellström-Lindberg E
Review: JOURNAL OF INTERNAL MEDICINE. 2011;269(2):137-147

Clinical impact of chromosomal aberrations in multiple myeloma.

Nahi H; Sutlu T; Jansson M; Alici E; Gahrton G
Meeting abstract: LEUKEMIA RESEARCH. 2009;33:S49-S50

Maintenance treatment with 5-azacitidine for patients with high risk myelodysplastic syndrome (MDS) or acute myeloid leukemia following MDS (MDS-AML) in complete remission (CR) after induction chemotherapy

Groevdal M; Kahn R; Jansson M; Aggerholm A; Antunovic P; Astermark J; Bernell P; Engstroem L; Kjeldsen L; Linder O; Nilsson L; Olsson A; Skovholm M; Tangen J
Meeting abstract: LEUKEMIA RESEARCH. 2009;33:S48

Lenalidomide abrogates the clonal advantage of del(5q) MDS stem cells via alteration of niche interactions

Scharenberg C; Jadersten M; Palmquist J; Forsblom L; Jansson M; Hellstrom-Lindberg E
Letter: BRITISH JOURNAL OF HAEMATOLOGY. 2009;144(2):266-268

The prognostic significance of 8p21 deletion in multiple myeloma.

Sutlu T; Alici E; Jansson M; Wallblom A; Dilber MS; Gahrton G; Nahi H
Letter: BRITISH JOURNAL OF HAEMATOLOGY. 2008;143(5):751-753

Transmission of chronic lymphocytic leukaemia from a blood stem cell sibling donor to the recipient.

Nahi H; Jansson M; Sander B; Ljungman P; Hägglund H

Employments

Affiliated to Research, Department of Medicine, Huddinge, Karolinska Institutet, 2023-2026

Degrees and Education

Licentiate Degree, Department of Laboratory Medicine, Karolinska Institutet, 2007
Bachelor Of Medical Science, Karolinska Institutet, 2001

About me

Research

Articles

All other publications

Employments

Degrees and Education

News from KI

Events from KI